The Canadian producer's bottom line worsened during the first quarter of legalized marijuana sales.
Great clinical results for its experimental atopic dermatitis drug provided a huge catalyst for Dermira.
Not all marijuana stocks are alike. These three have a competitive edge that their rivals don't.
If you're even thinking about buying this hot marijuana stock, read this first.
Which stock wins in a head-to-head battle between the top U.S. cannabis retailer and the Canadian marijuana streaming company?
Exact Sciences is hotter right now. But could Illumina be the bigger winner over the long run?
The big-pharma company could be in much better shape than you think.
This marijuana stock is hot right now. But here's what you need to know before jumping on the HEXO bandwagon.
Which stock wins in a matchup between these two top Canadian marijuana producers?
Tilray announces its Q4 results on Monday. Here's what you're likely to hear in the Canadian marijuana producer's update.
Which stock wins in a battle between these two big biotechs?
Which stock wins in a matchup between a top Canadian marijuana producer and a leading cannabinoid drugmaker?
Keep your eyes on these three hot diabetes stocks this month.
An FDA delay was seen as good news for the drugmaker.
The Canadian marijuana producer delivers tremendous sales growth in its latest quarter and has additional production capacity on the way.
This high-flying biotech stock is taking a breather. Time to buy?
Three of the biggest Canadian pot companies made the list.
Investors headed for the hills after the biotech's regulatory filing said that it could run out of cash in the not-too-distant future.
With Aurora's addition of a well-connected strategic advisor, should investors be looking for big deals on the way?
A new strategic advisor could improve Aurora's chances of landing a major partner outside of the cannabis industry.